Viewing Study NCT00314912


Ignite Creation Date: 2025-12-26 @ 11:13 PM
Ignite Modification Date: 2025-12-26 @ 11:13 PM
Study NCT ID: NCT00314912
Status: UNKNOWN
Last Update Posted: 2007-07-16
First Post: 2006-04-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's Disease
Sponsor: Bellus Health Inc. - a GSK company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module